Point72 Asset Management, L.P. - May 12, 2025 SCHEDULE 13G Report for CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX)

Filing Manager: Point72 Asset Management, L.P.
Reporting Manager: Point72 Asset Management, L.P.
Security: CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol: CTMX
Shares outstanding: 158M shares
Disclosed Ownership: 13.1M shares
Ownership: 8.3%
Form type: SCHEDULE 13G
Date filed: 5/14/2025, 05:14 PM
Date of event: May 12, 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Point72 Asset Management, L.P.	8.3%	13.1M	13.1M	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc.	8.3%	13.1M	13.1M	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person
Steven A. Cohen	8.3%	13.1M	13.1M	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person

Showing 1 to 3 of 3 entries